Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limitation of the effectiveness of inhalation training in patients with asthma and COPD.

Respiratory medicine·2025
Same author

Expectations Versus Reality in Inhalation Technique-A Case-Control Study of Inhalation Technique in Patients with Asthma or COPD.

Journal of clinical medicine·2025
Same author

Endothelial Cell Apoptosis but Not Necrosis Is Inhibited by Ischemic Preconditioning.

International journal of molecular sciences·2024
Same author

Sympathetic skin response in obstructive sleep apnea syndrome.

Acta neurobiologiae experimentalis·2023
Same author

Serum Amyloid A in Stable Patients with Chronic Obstructive Pulmonary Disease Does Not Reflect the Clinical Course of the Disease.

International journal of molecular sciences·2023
Same author

Primary antiphospholipid syndrome in a male with myocardial infarction with non-obstructive coronary arteries and a history of stroke.

Kardiologia polska·2022

Related Experiment Video

Updated: May 10, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

[GOLD 2011 - COPD from a new perspective].

Renata Rubinsztajn1, Tadeusz Przybyłowski, Marta Maskey-Warzechowska

  • 1Warszawski Uniwersytet Medyczny, Katedra i Klinika Chorób Wewngtrznych, Pneumonologii i Alergologii. rrubinsztajn@wum.edu.pl

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|June 11, 2013
PubMed
Summary

The GOLD 2011 guidelines for chronic obstructive pulmonary disease (COPD) offer improved treatment optimization. However, classifying patients with severe obstruction but few exacerbations, or mild obstruction with frequent exacerbations, presents challenges.

More Related Videos

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Related Experiment Videos

Last Updated: May 10, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Guidelines

Background:

  • The Global Initiative for Chronic Obstructive Lung Disease (GOLD) updated its recommendations in 2011.
  • The new GOLD 2011 classification incorporates FEV1, breathlessness (mMRC/CAT scores), and exacerbation frequency.
  • Previous GOLD 2010 guidelines primarily relied on FEV1 for staging.

Purpose of the Study:

  • To compare the GOLD 2010 and GOLD 2011 COPD classification systems.
  • To evaluate the practical application of the GOLD 2011 guidelines in patient stratification.
  • To identify potential difficulties in applying the new COPD classification.

Main Methods:

  • A cohort of 143 patients with COPD was studied.
  • Patients were initially staged using GOLD 2010 criteria (FEV1-based).
  • Subsequent grading utilized GOLD 2011 criteria, including exacerbation history and modified MRC dyspnea scores.

Main Results:

  • Applying GOLD 2011 criteria proved challenging for 35.7% of patients.
  • Specific difficulties arose in classifying patients with GOLD stage I/II and >=2 exacerbations, and GOLD stage III/IV with <2 exacerbations.
  • These challenging cases were often assigned to higher risk groups under the new system.

Conclusions:

  • The GOLD 2011 classification generally allows for treatment optimization in COPD patients.
  • Clinical practice may encounter difficulties classifying patients with severe obstruction and low exacerbation rates.
  • Patients with mild/moderate airflow limitation and frequent exacerbations also pose classification challenges.